j9九游会Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

发布时间： 2016-10-14 浏览次数： 73

Hao C, Li X, JingL, et al. Tamoxifen therapy benefit predictive signature coupled withprognostic signature of post-operative recurrent risk for early stage ER+breast cancer[J]. Oncotarget, 2015, 6(42):44593-44608.点击下载

map